Costs of isocyanate-related occupational diseases: A systematic review

References

• International Labour Organization: International Labour Conference. Presentation of a Protocol and two Recommendations adopted at the 90th Session of the International Labour Conference (2002) and the proposed action by Her Majesty’s Government in the United Kingdom of Great Britain and Northern Ireland on the Protocol and Recommendations, 2003. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/273200/5870.pdf (accessed September 8, 2016).
   Google Scholar
• Gibson, G.J., R. Loddenkemper, Y. Sibille, and B. Lundbäck: The European Lung White Book. Respiratory Health and Disease in Europe. Sheffield, UK: European Respiratory Society; 2013.
   Google Scholar
• De Craecker, W., N. Roskams, and R. Op de Beeck: Occupational skin diseases and dermal exposure in the European Union (EU-25). Policy and practice overview. Luxembourg: Office for Official Publications of the European Communities, 2008.
   Google Scholar
• International Labour Organization: ILO List of Occupational Diseases (revised 2010); 2010. Available at http://www.ilo.org/wcmsp5/groups/public/—ed_protect/—protrav/—safework/documents/publication/wcms_125137.pdf (accessed September 8, 2016).
   Google Scholar
• Verschoor, L., and A.H. Verschoor: Nonoccupational and occupational exposure to isocyanates. Curr. Opin. Pulm. Med. 20:199–204 (2014).
   PubMed Web of Science ®Google Scholar
• Vandenplas, O., J.-L- Malo, M. Saetta, C.E. Mapp, and L. Fabbri: Occupational asthma and extrinsic alveolitis due to isocyanates: Current status and perspectives. Br. J. Ind. Med. 50:213–228 (1993).
   PubMedGoogle Scholar
• Nakashima, K., T. Takeshita, and K. Morimoto: Review of the occupational exposure to isocyanates: Mechanisms of action. Environ. Health Prev. Med. 7:1–6 (2002).
   PubMedGoogle Scholar
• Nakashima, K., T. Takeshita, and K. Morimoto: Diagnosis and prevention of diseases induced by isocyanate. Environ. Health Prev. Med. 7:40–46 (2002).
   PubMedGoogle Scholar
• Fisseler-Eckhoff, A., H. Bartsch, R. Zinsky, and J. Schirren: Environmental isocyanate-induced asthma: Morphologic aspects of an increasing occupational disease. Int. J. Environ. Res. Public Health 8:3672–3687 (2011).
   PubMed Web of Science ®Google Scholar
• Baur, X.: Hypersensitivity pneumonitis (extrinsic allergic alevolitis) induced by isocyanates. J. Allergy Clin. Immunol. 95:1004–10 (1995).
   PubMed Web of Science ®Google Scholar
• Nakashima, K., T. Takeshita, and K. Morimoto: Occupational hypersensitivity pneumonitis due to isocyanates: Mechanisms of action and case reports in Japan. Ind. Health 39:269–279 (2001).
   PubMed Web of Science ®Google Scholar
• Sirajuddin, A., and J.P. Kanne: Occupational lung disease. J. Thorac Imag. 24:310–320 (2009).
   PubMed Web of Science ®Google Scholar
• Uranga, A., M. Sanchez-Ortiz, F. Morrell, M.-J. Cruz, and X. Munoz: Hypersensitivity pneumonitis due to isocyanates: Lung function, clinical and radiological characteristics. Arch. Bronconeumol. 49:169–72 (2013).
   PubMed Web of Science ®Google Scholar
• Spagnolo, P., G. Rossi, A. Cavazza, et al.: Hypersensitivity pneumonitis: A comprehensive review. J. Invest. Allergol. Clin. Immunol. 25:237–250 (2015).
   PubMed Web of Science ®Google Scholar
• Redlich, C.A.: Skin exposure and asthma: Is there a connection? Proc. Am. Thorac. Soc. 7:134–137 (2010).
   PubMedGoogle Scholar
• Redlich, C.A., and C.A. Herrick: Lung/skin connections in occupational lung disease. Curr. Opin. Allergy Clin. Immunol. 8:115–119 (2008).
   PubMed Web of Science ®Google Scholar
• Bello, D., C.A. Herrick, T.J. Smith, et al.: Skin exposure to isocyanates: Reasons for concern. Environ. Health Perspect. 115:328–335 (2006).
   PubMed Web of Science ®Google Scholar
• European Union. Health and Safety at Work in Europe. (1999–2007): A Statistical Portrait. Luxembourg: EUR-OP; 2010.
   Google Scholar
• Diepgen, T.L.: Occupational skin-disease data in Europe. Int. Arch. Occup. Environ. Health 76:331–338 (2003).
   PubMed Web of Science ®Google Scholar
• European Agency for Safety and Health at Work: New and Emerging Risks in Occupational Safety and Health. European Risk Observatory. Luxembourg: EUR-OP, 2009.
   Google Scholar
• Spreeuwers, D., A.G. de Boer, J.H. Verbeek, and F.J.H. van Dijk: Evaluation of occupational disease surveillance in six EU countries. Occup. Med. 60:509–516 (2010).
   Google Scholar
• Drossard, C., and G. Lotz: P294 EU-wide data compilation of isocyanate-related occupational diseases. Occup. Environ. Med. 73:A220.1–A220 (2016).
   Google Scholar
• Pauluhn, J.: Animal models for respiratory hypersensitivity. In Encyclopedia of Immunotoxicology, 2nd ed., Vohr H.-W. (ed.), Berlin, Heidelberg, New York, 2016. pp. 19–26.
   Google Scholar
• Diepgen, T.L.: Occupational skin diseases. J. Dtsch. Dermatol. Ges. 10:297–315 (2012).
   PubMed Web of Science ®Google Scholar
• Ruhl, R., and H. Wriedt.: Some economic benefits of REACH. Ann. Occup. Hyg. 50:541–544 (2006).
   PubMedGoogle Scholar
• Moher, D., A. Liberati, J. Tetzlaff, and D.G. Altman: Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann. Intern. Med. 151:264–269 (2009).
   PubMed Web of Science ®Google Scholar
• German Institute of Medical Documentation and Information (DIMDI): Database Search, 2016. Available at https://www.dimdi.de/static/en/db/index.htm (accessed September 5, 2016).
   Google Scholar
• Baur, X., Bakehe, P., and H. Vellguth: Bronchial asthma and COPD due to irritants in the workplace — An evidence-based approach. J. Occup. Med. Toxicol. 7:19 (2012).
   PubMed Web of Science ®Google Scholar
• Verschoor, L., and A.H. Verschoor: Nonoccupational and occupational exposure to isocyanates. Curr. Opin. Pul. Med. 20:199–204 (2014).
   PubMed Web of Science ®Google Scholar
• Mattioli, S., F. Zanardi, A. Baldasseroni, et al.: Search strings for the study of putative occupational determinants of disease. Occup. Environ. Med. 67:436–443 (2010).
   PubMed Web of Science ®Google Scholar
• Institute for Quality and Efficieny in Health Care (IQWIG): Kosten-Nutzen-Bewertung von Clopidogrel bei der peripheren arteriellen Verschlusskrankheit und beim akuten Koronarsyndrom. [Health economic evaluation of clopidrogel in acute coronary syndrome and in peripheral occlusive arterial disease], 2011. Available at https://www.iqwig.de/download/G09-02_DWA_Berichtsplan_Kosten-Nutzen-Bewertung_von_Clopidogrel.pdf (accessed November 9, 2016).
   Google Scholar
• Molinier, L., E. Bauvin, C. Combescure, et al.: Methodological considerations in cost of prostate cancer studies: A systematic review. Value Health 11:878–885 (2008).
   PubMed Web of Science ®Google Scholar
• Costa, N., H. Derumeaux, T. Rapp, et al.: Methodological considerations in cost of illness studies on Alzheimer disease. Health Econ. Rev. 2:18 (2012).
   PubMedGoogle Scholar
• Stuhldreher, N., A. Konnopka, B. Wild, et al.: Cost-of-illness studies and cost-effectiveness analyses in eating disorders: A systematic review. Int. J. Eat. Disord. 45:476–491 (2012).
   PubMed Web of Science ®Google Scholar
• Kleine-Budde, K., E. Touil, J. Moock, A. Bramesfeld, W. Kawohl, and W. Rössler: Cost of illness for bipolar disorder: A systematic review of the economic burden. Bipolar Disord. 16:337–353 (2014).
   PubMed Web of Science ®Google Scholar
• Reeb-Whitaker, C., N.J. Anderson, and D.K. Bonauto: Prevention guidance for isocyanate-induced asthma using occupational surveillance data. J. Occup. Environ. Hyg. 10:597–608 (2013).
   PubMed Web of Science ®Google Scholar
• Ayres, J.G., R. Boyd, H. Cowie, and J.F. Hurley: Costs of occupational asthma in the UK. Thorax 66:128–133 (2010).
   PubMed Web of Science ®Google Scholar
• Malo, J., J. L’Archevêque, and H. Ghezzo: Direct costs of occupational asthma in Quebec between 1988 and 2002. Can. Respir. J. 15:413–416 (2008).
   PubMed Web of Science ®Google Scholar
• Moscato, G., A. Dellabianca, L. Perfetti, B. Bramè, E. Galdi, R. Niniano, and P. Paggiaro: Occupational asthma: A longitudinal study on the clinical and socioeconomic outcome after diagnosis. Chest 249–256 (1999).
   PubMed Web of Science ®Google Scholar
• Ameille, J., J. Pairon, M.C. Bayeux, et al.: Consequences of occupational asthma on employment and financial status: A follow-up study. Eur. Respir. J. 10:55–58 (1997).
   PubMed Web of Science ®Google Scholar
• Gannon, P.F., D.C. Weir, A.S. Robertson, and P.S. Burge: Health, employment, and financial outcomes in workers with occupational asthma. Br. J. Ind. Med. 50:491–496 (1993).
   PubMedGoogle Scholar
• García Gómez, M., R. Urbanos Garrido, R. Castañeda López, and P.L. Menduiña: Direct health care costs of occupational asthma in Spain: An estimation from 2008. Arch. Bronconeumol. 48:355–361 (2012).
   PubMed Web of Science ®Google Scholar
• Leigh, J.P., P.S. Romano, M.B. Schenker, and K. Kreiss: Costs of occupational COPD and asthma. Chest 121:264–272 (2002).
   PubMed Web of Science ®Google Scholar
• Leigh, J.P., S. Yasmeen, and T.R. Miller: Medical costs of fourteen occupational illnesses in the United States in 1999. Scand. J. Work Environ. Health 29:304–313 (2003).
   PubMed Web of Science ®Google Scholar
• Leira, H.L., U. Bratt, and S. Slåstad: Notified cases of occupational asthma in Norway: Exposure and consequences for health and income. Am. J. Ind. Med. 48:359–364 (2005).
   PubMed Web of Science ®Google Scholar
• Miedinger, D., K.L. Lavoie, J. L’Archevêque, H. Ghezzo, M.V. Zunzunuegui, and J.L. Malo: Quality-of-life, psychological, and cost outcomes 2 years after diagnosis of occupational asthma. J. Occup. Environ. Med. 53:231–238 (2011).
   PubMed Web of Science ®Google Scholar
• Diepgen, T.L., R. Scheidt, E. Weisshaar, S.M. John, and K. Hieke: Cost of illness from occupational hand eczema in Germany. Contact Dermatitis. 69:99–106 (2013b).
   PubMed Web of Science ®Google Scholar
• Diepgen, T., S. Purwins, J. Posthumus, D. Kuessner, S.M. John, and M. Augustin: Cost-of-illness analysis of patients with chronic hand eczema in routine care in Germany: Focus on the impact of occupational disease. Acta Derm. Venerol. 93:538–543 (2013a).
   PubMed Web of Science ®Google Scholar
• Saetterstrøm, B., J. Olsen, and J.D. Johansen: Cost-of-illness of patients with contact dermatitis in Denmark. Contact Dermatitis. 71:154–161 (2014).
   PubMed Web of Science ®Google Scholar
• Lyons, G., T. Keegel, A. Palmer, and R. Nixon: Occupational dermatitis in hairdressers: Do they claim workers' compensation? Contact Dermatitis. 68:163–168 (2013).
   PubMed Web of Science ®Google Scholar
• McCall, B.P., I.B. Horwitz, S.R. Feldman, and R. Balkrishnan: Incidence rates, costs, severity, and work-related factors of occupational dermatitis. Arch. Dermatol. 141:713–718 (2005).
   PubMedGoogle Scholar
• Augustin, M., D. Kuessner, S. Purwins, K. Hieke, J. Posthumus, and T.L. Diepgen: Cost-of-illness of patients with chronic hand eczema in routine care: Results from a multicentre study in Germany. Br J Dermatol. 165:845–851 (2011).
   PubMed Web of Science ®Google Scholar
• European Chemicals Agency (ECHA): European Regulation for the Registration, Evaluation, Authorisation in Chemicals (REACH); 2016. Available at https://echa.europa.eu/regulations/reach (accessed October 25, 2016).
   Google Scholar